These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

396 related articles for article (PubMed ID: 22326264)

  • 41. Mineralocorticoid receptor function in bone metabolism and its role in glucocorticoid-induced osteopenia.
    Fumoto T; Ishii KA; Ito M; Berger S; Schütz G; Ikeda K
    Biochem Biophys Res Commun; 2014 May; 447(3):407-12. PubMed ID: 24713303
    [TBL] [Abstract][Full Text] [Related]  

  • 42. 17Beta-estradiol inhibits 11beta-hydroxysteroid dehydrogenase type 1 activity in rodent adipocytes.
    Tagawa N; Yuda R; Kubota S; Wakabayashi M; Yamaguchi Y; Kiyonaga D; Mori N; Minamitani E; Masuzaki H; Kobayashi Y
    J Endocrinol; 2009 Jul; 202(1):131-9. PubMed ID: 19380458
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Differential expression of determinants of glucocorticoid sensitivity in androgen-dependent and androgen-independent human prostate cancer cell lines.
    Dovio A; Sartori ML; De Francia S; Mussino S; Perotti P; Saba L; Abbadessa G; Racca S; Angeli A
    J Steroid Biochem Mol Biol; 2009 Aug; 116(1-2):29-36. PubMed ID: 19406240
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Possible involvement of glucocorticoids in 5α-dihydrotestosterone-induced PCOS-like metabolic disturbances in the rat visceral adipose tissue.
    Nikolić M; Macut D; Djordjevic A; Veličković N; Nestorović N; Bursać B; Antić IB; Macut JB; Matić G; Vojnović Milutinović D
    Mol Cell Endocrinol; 2015 Jan; 399():22-31. PubMed ID: 25179821
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Alternative mechanism for anti-obesity effect of dehydroepiandrosterone: possible contribution of 11β-hydroxysteroid dehydrogenase type 1 inhibition in rodent adipose tissue.
    Tagawa N; Minamitani E; Yamaguchi Y; Kobayashi Y
    Steroids; 2011 Dec; 76(14):1546-53. PubMed ID: 21945397
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Attenuation of cold stress-induced exacerbation of cardiac and adipose tissue pathology and metabolic disorders in a rat model of metabolic syndrome by the glucocorticoid receptor antagonist RU486.
    Nagasawa K; Matsuura N; Takeshita Y; Ito S; Sano Y; Yamada Y; Uchinaka A; Murohara T; Nagata K
    Nutr Diabetes; 2016 Apr; 6(4):e207. PubMed ID: 27110688
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Induction of FKBP51 by aldosterone in intestinal epithelium.
    Petrovich E; Asher C; Garty H
    J Steroid Biochem Mol Biol; 2014 Jan; 139():78-87. PubMed ID: 24139875
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Blockage of glucocorticoid, but not mineralocorticoid receptors prevents the persistent increase in circulating basal corticosterone concentrations following stress in the rat.
    Moldow RL; Beck KD; Weaver S; Servatius RJ
    Neurosci Lett; 2005 Feb; 374(1):25-8. PubMed ID: 15631890
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Role of glucocorticoid receptor and CCAAT/enhancer-binding protein alpha in the feed-forward induction of 11beta-hydroxysteroid dehydrogenase type 1 expression by cortisol in human amnion fibroblasts.
    Yang Z; Guo C; Zhu P; Li W; Myatt L; Sun K
    J Endocrinol; 2007 Nov; 195(2):241-53. PubMed ID: 17951535
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Contribution of mineralocorticoid and glucocorticoid receptors to the chronotropic and hypertrophic actions of aldosterone in neonatal rat ventricular myocytes.
    Rossier MF; Python M; Maturana AD
    Endocrinology; 2010 Jun; 151(6):2777-87. PubMed ID: 20392829
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Decreased hippocampal mineralocorticoid:glucocorticoid receptor ratio is associated with low birth weight in female cynomolgus macaque neonates.
    Ong SX; Chng K; Meaney MJ; Buschdorf JP
    J Mol Endocrinol; 2013; 51(1):59-67. PubMed ID: 23592886
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Changes in adipose glucocorticoid metabolism before and after bariatric surgery assessed by direct hormone measurements.
    Methlie P; Dankel S; Myhra T; Christensen B; Gjerde J; Fadnes D; Våge V; Løvås K; Mellgren G
    Obesity (Silver Spring); 2013 Dec; 21(12):2495-503. PubMed ID: 23512832
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Mineralocorticoid receptor blockade prevents vascular remodelling in a rodent model of type 2 diabetes mellitus.
    Silva MA; Cau SB; Lopes RA; Manzato CP; Neves KB; Bruder-Nascimento T; Mestriner FL; Montezano AC; Nguyen Dinh Cat A; Touyz RM; Tostes RC
    Clin Sci (Lond); 2015 Oct; 129(7):533-45. PubMed ID: 25967696
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Deep subcutaneous adipose tissue: a distinct abdominal adipose depot.
    Walker GE; Verti B; Marzullo P; Savia G; Mencarelli M; Zurleni F; Liuzzi A; Di Blasio AM
    Obesity (Silver Spring); 2007 Aug; 15(8):1933-43. PubMed ID: 17712110
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Fructose consumption enhances glucocorticoid action in rat visceral adipose tissue.
    Bursać BN; Djordjevic AD; Vasiljević AD; Milutinović DD; Veličković NA; Nestorović NM; Matić GM
    J Nutr Biochem; 2013 Jun; 24(6):1166-72. PubMed ID: 23253598
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Novel fat depot-specific mechanisms underlie resistance to visceral obesity and inflammation in 11 β-hydroxysteroid dehydrogenase type 1-deficient mice.
    Wamil M; Battle JH; Turban S; Kipari T; Seguret D; de Sousa Peixoto R; Nelson YB; Nowakowska D; Ferenbach D; Ramage L; Chapman KE; Hughes J; Dunbar DR; Seckl JR; Morton NM
    Diabetes; 2011 Apr; 60(4):1158-67. PubMed ID: 21350084
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Combined antagonist treatment of glucocorticoid and mineralocorticoid receptor does not affect weight loss of fasting rainbow trout but inhibits a fasting-induced elevation of cortisol secretion.
    Pfalzgraff T; Skov PV
    Comp Biochem Physiol A Mol Integr Physiol; 2022 Dec; 274():111321. PubMed ID: 36169060
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A second enzyme protecting mineralocorticoid receptors from glucocorticoid occupancy.
    Morris DJ; Latif SA; Rokaw MD; Watlington CO; Johnson JP
    Am J Physiol; 1998 May; 274(5):C1245-52. PubMed ID: 9612211
    [TBL] [Abstract][Full Text] [Related]  

  • 59. SGK1 is regulated by metabolic-related factors in 3T3-L1 adipocytes and overexpressed in the adipose tissue of subjects with obesity and diabetes.
    Li P; Pan F; Hao Y; Feng W; Song H; Zhu D
    Diabetes Res Clin Pract; 2013 Oct; 102(1):35-42. PubMed ID: 24035040
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Gene expression effects of glucocorticoid and mineralocorticoid receptor agonists and antagonists on normal human skeletal muscle.
    Chadwick JA; Hauck JS; Gomez-Sanchez CE; Gomez-Sanchez EP; Rafael-Fortney JA
    Physiol Genomics; 2017 Jun; 49(6):277-286. PubMed ID: 28432191
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.